Ongoing efforts in the discovery of small molecule inhibitors targeting the HIV integrase–LEDGF/p75 interaction [114,115] may potentially yield LEDGF/p75 inhibitors that could be repurposed for the treatment of advanced PCa in combination with SMGRs and taxanes. Here, PSIP1 is linked to posterior cortical atrophy.